Project Grant RF1NS122028

Award Date 2/1/22
Completion Date 1/31/25
Dollars Obligated $1.6M
Funding Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40526, USA
Similar Awards
This $2,762,736 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program aims to develop and optimize a high-resolution diffusion-weighted arterial spin labeling (DW-ASL) technique and mathematical models to non-invasively quantify blood-brain barrier (BBB) water exchange rate (Kw) and permeability surface area product (Psw)...
This $4.8 million project grant from the National Institutes of Health's National Institute on Aging Aging Research program (CFDA 93.866) will fund research into vascular contributors to blood-brain barrier permeability and regional white matter hyperintensity progression in asymptomatic individuals ages 40-50. The Johns Hopkins University will study how periventricular and deep white matter hyperintensities independently progress and influence clinical outcomes, and how increasing blood-brain...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $4,361,625 to The Washington University to investigate the pathogenesis of cerebral small vessel disease (CSVD) and vascular contributions to dementia (VCID). The key objectives are to: Identify cerebrospinal fluid proteins and metabolites related to different white...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $801,476 is focused on studying cerebrovascular reactivity (CVR) as a potential biomarker for vascular contributions to cognitive impairment and dementia (VCID) in patients with CADASIL, a rare genetic form of small vessel disease. The University of Wisconsin-Madison is the prime awardee and will leverage an existing longitudinal cohort of 400 CADASIL patients with NOTCH3 gene...
This $1,120,805 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), will support research to investigate how prior SARS-CoV-2 infection may increase the risk of vascular contributions to cognitive impairment and dementia (VCID). The research aims to: Determine how prior SARS-CoV-2 infection influences blood-brain barrier...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to create an inter-Alzheimer's Disease Research Center (ADRC) set of objectively measured cerebral small vessel disease (SVD) magnetic resonance imaging (MRI) biomarkers from large and diverse clinical cohorts. The $790,491 award will fund the development and validation of novel deep-learning methods to accurately quantify SVD biomarkers, including cerebral microbleeds, white matter...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $758,744 to The University of Kentucky Research Foundation to conduct research aimed at understanding the mechanisms of blood-brain barrier dysfunction in Alzheimer's disease and developing therapeutic strategies to repair this dysfunction. The key objectives of the research are to: 1) Identify the signaling mechanisms by which the protein tau induces blood-brain barrier...
This federal Project Grant award, issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $4,693,249 to the University of California, Los Angeles (UCLA) to conduct research on defining the molecular spectrum of white matter vascular lesions that drive vascular cognitive impairment and dementia (VCID). The project aims to develop a better understanding of...
This Project Grant award for $2,398,590.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the role of brain microcirculation and capillary endothelial cell energetics in the development of vascular cognitive impairment and dementia (VCID) observed in Alzheimer's disease (AD) and AD-related dementias. The...
This $185,913 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to examine sex differences in cerebral small vessel disease (CSVD) and Alzheimer's disease (AD). The primary objectives are to: Measure white matter integrity, functional brain connectivity, and cognitive function in individuals genetically predisposed to developing...

REDUCED BBB WATER EXCHANGE AS A PRECLINICAL BIOMARKER OF SMALL VESSEL DISEASE - REDUCED BBB WATER EXCHANGE AS A PRECLINICAL BIOMARKER OF SMALL VESSEL DISEASE VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA (VCID) IS COMMON IN OLDER ADULTS AND IS A MAJOR PUBLIC HEALTH RISK. VCID AFFECTS THE NETWORK OF SMALL BLOOD VESSELS THAT SUPPLY ALL PARTS OF THE BRAIN, RESULTING IN COGNITIVE DECLINE. CLINICAL TRIALS HAVE BEEN HAMPERED BY THE LACK OF NON- INVASIVE TOOLS TO DETECT EARLY STAGES OF VCID. CONSEQUENTLY, INNOVATIVE TOOLS FOR THE IDENTIFICATION OF EARLY-STAGE VCID HAVE BECOME A MAJOR RESEARCH PRIORITY. THE BLOOD-BRAIN BARRIER (BBB) MAY BE A KEY SYSTEM AFFECTED EARLY IN THE COURSE OF VCID. RECENT ADVANCES IN THE DEVELOPMENT OF A NOVEL DIFFUSION-WEIGHTED ASL (DW-ASL) SEQUENCE AND POST-PROCESSING ANALYSES HAVE MADE IT POSSIBLE TO QUANTIFY WATER EXCHANGE RATE ACROSS THE BBB, A METRIC OF BBB FUNCTIONING. OUR PRELIMINARY RESULTS USING THIS NOVEL SEQUENCE SUGGEST THAT LOW WATER EXCHANGE ACROSS THE BBB (LOW KW) IS ASSOCIATED WITH HIGH CONCENTRATIONS OF PLASMA VASCULAR INFLAMMATORY MARKERS AND POOR COGNITIVE PERFORMANCE, SUGGESTING THAT IT MAY REPRESENT AN EARLY MARKER OF VCID. LONGITUDINAL RESEARCH IS REQUIRED TO TEST THIS POSSIBILITY. THIS PROPOSAL SEEKS TO ASSESS THE ACCURACY OF LOW KW AS A PREDICTOR OF SUBSEQUENT NEUROCOGNITIVE DECLINES. WE WILL ALSO TEST THE POSSIBILITY THAT LOW KW IS ASSOCIATED WITH OXIDATIVE STRESS, ASSESSED VIA CEREBROSPINAL FLUID (CSF) ISOPROSTANE LEVELS. WE PROPOSE TO STUDY 140 HEALTHY OLDER ADULTS AT BASELINE USING DW-ASL, PLASMA INFLAMMATORY MARKERS AND CSF MEASURES OF ISOPROSTANES, ASS, P-TAU AND T-TAU. IN ADDITION, STRUCTURAL NEUROIMAGING MEASURES WILL BE OBTAINED AND QUANTIFIED, INCLUDING REGIONAL VOLUMES, WHITE MATTER HYPERINTENSITY (WMH) VOLUMES, DIFFUSION TENSOR IMAGING FOR QUANTIFICATION OF REGIONALLY DISTRIBUTED WHITE MATTER ABNORMALITIES AND SUSCEPTIBILITY WEIGHTED IMAGING FOR QUANTIFICATION OF CEREBRAL MICROBLEEDS. A SUBSET OF PARTICIPANTS WILL COMPLETE THE SAME NEUROIMAGING AND BIOFLUID MEASURES APPROXIMATELY 3 YEARS LATER. WE AIM TO IDENTIFY THE RELATIONSHIP BETWEEN BASELINE BBB WATER EXCHANGE AND SUBSEQUENT WMH GROWTH (AIM 1); COGNITIVE DECLINES (AIM 2) AND BIOFLUID INDICES OF OXIDATIVE STRESS (AIM 3). THE OVERALL HYPOTHESIS WE WILL TEST IS THAT THAT LOW WATER EXCHANGE RATE ASSESSED WITH A NOVEL DW-ASL SEQUENCE REPRESENTS AN EARLY MARKER BBB DYSFUNCTION ASSOCIATED WITH LATER WMH GROWTH, COGNITIVE DECLINES AND OXIDATIVE STRESS.

Posted 1/31/22, 12:00 AM